Starpharma Holdings Limited (ASX:SPL) Insider Robert Thomas Buys 150,000 Shares

Starpharma Holdings Limited (ASX:SPLGet Free Report) insider Robert Thomas bought 150,000 shares of the firm’s stock in a transaction that occurred on Wednesday, May 29th. The stock was bought at an average price of A$0.12 ($0.08) per share, with a total value of A$17,700.00 ($11,879.19).

Robert Thomas also recently made the following trade(s):

  • On Wednesday, April 10th, Robert Thomas purchased 250,000 shares of Starpharma stock. The stock was bought at an average cost of A$0.17 ($0.12) per share, with a total value of A$43,500.00 ($29,194.63).
  • On Monday, April 15th, Robert Thomas bought 100,000 shares of Starpharma stock. The shares were purchased at an average cost of A$0.13 ($0.09) per share, for a total transaction of A$13,000.00 ($8,724.83).

Starpharma Price Performance

The company has a debt-to-equity ratio of 9.08, a quick ratio of 5.65 and a current ratio of 5.60.

Starpharma Company Profile

(Get Free Report)

Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company offers VivaGel BV, a non-antibiotic vaginal gel for the treatment of bacterial vaginosis and prevention of recurrent BV; VIRALEZE, an antiviral nasal spray; and VivaGel condom, an antiviral condom.

Read More

Receive News & Ratings for Starpharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Starpharma and related companies with MarketBeat.com's FREE daily email newsletter.